Karnan, Sivasundaram
Hanamura, Ichiro
Ota, Akinobu http://orcid.org/0000-0002-6296-2921
Takasugi, Souichi
Nakamura, Ayano
Takahashi, Miyuki
Uchino, Kaori http://orcid.org/0000-0003-2983-2129
Murakami, Satsuki
Wahiduzzaman, Md
Quang Vu, Lam
Rahman, Md Lutfur
Hasan, Muhammad Nazmul http://orcid.org/0000-0003-2536-7557
Hyodo, Toshinori
Konishi, Hiroyuki http://orcid.org/0000-0003-1131-4905
Tsuzuki, Shinobu
Yoshikawa, Kazuhiro
Suzuki, Susumu
Ueda, Ryuzo
Ejiri, Masayuki
Hosokawa, Yoshitaka
Takami, Akiyoshi http://orcid.org/0000-0002-1822-9976
Article History
Received: 2 October 2020
Revised: 22 January 2021
Accepted: 9 March 2021
First Online: 25 May 2021
Ethics statement
: This research complies with the ethical guidelines of the Japanese Ministry of Health, Labour and Welfare.
: I.H. received honoraria and/or membership on an entity’s board of directors, speakers’ bureau, or advisory committees from Celgene, Janssen, Takeda, Ono, Bristol-Myers Squibb (BMS), Novartis, Daiichi Sankyo, Kyowa Kirin, Eisai, Nihon-Shinyaku, Pfizer, AbbVie, Otsuka, Shionogi, Mundi, CSL Behring, and Merck Sharp & Dohme (MSD). I.H. and A.T. received research funding from BMS, MSD, Astellas, Otsuka, Ono, Kyowa Kirin, Sanofi, Shionogi, Zenyaku, Daiichi Sankyo, Taiho, Takeda, Chugai, Eli Lilly, Nihon Shinyaku, Novartis, Pfizer, Celgene, Fukuyu Hospital, and Yamada Yohojo. RU received research funding from Kyowa Kirin, Chugai Pharmaceutical, and Ono Pharmaceutical. The remaining authors declare no competing financial interests.